Danaher Corporation (DHR): SVP-Chief Legal Officer received 2,374 shares
Jonathan Leiken, SVP-Chief Legal Officer at Danaher Corporation, reported a grant / award of 2,374 shares.
- 2,374
- Shares
- Traded
- Mar 1, 2026
- Filed
- Mar 4, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 28, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Dec 18, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 16, 2026FDAFDA device clearance: Xpert GI Panel
- Jan 27, 2026FDAFDA device clearance: Access anti-HAV IgM
- Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 30, 2026FDARecall: CHEMISTRY ANALYZER AU5800, REF: B96697, B96698, B23279, B23280, B23281
- Jan 30, 2026FDARecall: DxC 700 AU, REF: B86444, B86446
- Jan 30, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 8.6%
- Feb 5, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 5, 2026, Jessica L. Mega notified Danaher Corporation’s (“Danaher”) Board of Directors (“Board”) of her retirement from the Board as of February 5, 2026, due to commitments related to her other professional obligations.”
- Feb 19, 2026FDAFDA device clearance: Access anti-HBc Total
- Feb 19, 2026InsiderOfficer sold ~$275K of DHR shares in the open market
- Feb 20, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
What came next
- Mar 13, 2026FDAFDA device clearance: Access anti-HBc IgM
- Mar 16, 2026FDARecall: Access Total T4 Calibrator, Catalog No. 33805
- Mar 24, 2026FDAFDA device clearance: Access BNP II
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 10, 2026FDAFDA device clearance: ABL90 FLEX PLUS System, safeCLINITUBES
- Apr 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 22, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Apr 29, 2026FDARecall: REMISOL Advance with Software Version 2.5 UDI-DI code: 15099590802073 The Normand Info REMISOL Advance Data Manager collects and manages data and workflow for…
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.7%
- May 1, 2026FDAFDA device clearance: ABL90 FLEX PLUS System
- May 1, 2026FDAFDA device clearance: ABL90 FLEX PLUS System
- May 1, 2026InsiderDirector sold ~$237K of DHR shares in the open market
- May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described in Item 5.07 below, the Company’s shareholders approved the Amended and Restated Danaher Corporation Omnibus Incentive Plan (the “Plan”).”
- Jun 3, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
- Jun 26, 2026FDARecall: REF # D23354, MicroScan LabPro V5.03 Panel Update 11 DVD Kit (US) on the following instruments: - B1018-280 MicroScan autoSCAN-4 Instrument - B1018-283 MicroSc…
- Jun 26, 2026FDARecall: REF # D23352, MicroScan LabPro V5.03 Panel Update 11 (US), Electronic installed on the following instruments: - B1018-280 MicroScan autoSCAN-4 Instrument - B10…
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Danaher Corporation
For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.
Other recent filings by Jonathan Leiken, SVP-Chief Legal Officer
The full history of Jonathan Leiken, SVP-Chief Legal Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Danaher Corporation (DHR) insider traded, and how much?
Jonathan Leiken, SVP-Chief Legal Officer at Danaher Corporation, reported a grant / award of 2,374 shares. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Mar 1, 2026. Filed: Mar 4, 2026. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Danaher Corporation recently?
For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.
Does this mean DHR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Danaher Corporation
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
Everything OQRO holds on this company is on its DHR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
